Gene · 3713
Papers3,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37511268 | PubTator, text mining | PubMed |
| An Update on S100A16 in Human Cancer. | Biomolecules | 2023 | 37509106 | PubTator, text mining | PubMed |
| Development of Spray Dried Spirulina Protein-Berry Pomace Polyphenol Particles to Attenuate Pollution-Induced Skin Damage: A Convergent Food-Beauty Approach. | Antioxidants (Basel) | 2023 | 37507969 | PubTator, text mining | PubMed |
| Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus. | Microbiome | 2023 | 37491398 | PubTator, text mining | PubMed |
| IL-17A exacerbates psoriasis in a STAT3 overexpressing mouse model. | PeerJ | 2023 | 37465147 | PubTator, text mining | PubMed |
| The effect of long-term cigarette smoking on selected skin barrier proteins and lipids. | Sci Rep | 2023 | 37463939 | PubTator, text mining | PubMed |
| Adult eosinophilic esophagitis and advances in its treatment. | World J Methodol | 2023 | 37456973 | PubTator, text mining | PubMed |
| Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers. | J Cancer Res Clin Oncol | 2023 | 37453969 | PubTator, text mining | PubMed |
| Topical Application of M89PF Containing Vichy Mineralising Water and Probiotic Fractions Prevents Cutaneous Damage Induced by Exposure to UV and O3. | Clin Cosmet Investig Dermatol | 2023 | 37448587 | PubTator, text mining | PubMed |
| Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3. | Int J Mol Sci | 2023 | 37445934 | PubTator, text mining | PubMed |
| A Sequential Micro-Immunotherapy Medicine Increases Collagen Deposition in Human Gingival Fibroblasts and in an Engineered 3D Gingival Model under Inflammatory Conditions. | Int J Mol Sci | 2023 | 37445663 | PubTator, text mining | PubMed |
| Molecular Characterization of Esophageal Squamous Cell Carcinoma Using Quantitative Proteomics. | Cancers (Basel) | 2023 | 37444412 | PubTator, text mining | PubMed |
| The difficulty of aligning intrinsically disordered protein sequences as assessed by conservation and phylogeny. | PLoS One | 2023 | 37440576 | PubTator, text mining | PubMed |
| One-year longitudinal study of the stratum corneum proteome of retinol and all-trans-retinoic acid treated human skin: an orchestrated molecular event. | Sci Rep | 2023 | 37433822 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy. | Front Oncol | 2023 | 37427102 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| Paraptosis: a unique cell death mode for targeting cancer. | Front Pharmacol | 2023 | 37397502 | PubTator, text mining | PubMed |
| Introducing a new type of alternative laryngeal mucosa model. | PLoS One | 2023 | 37390090 | PubTator, text mining | PubMed |
| In vitro percutaneous penetration test overview. | Front Pharmacol | 2023 | 37388444 | PubTator, text mining | PubMed |
| Down-regulation of peptidylarginine deiminase type 1 in reconstructed human epidermis disturbs nucleophagy in the granular layer and affects barrier function. | Cell Death Discov | 2023 | 37385992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/papers?page=14